Drug intelligence / Profile preview

Weili Tablets

Development stage: Unknown
Lead developer: Xian CP
Administration: Oral

Overview

Weili Tablets (also known as Weili Pian) is an approved traditional Chinese medicine (TCM) developed and manufactured by Xian Zhengda Pharmaceutical. It is formulated as an oral tablet containing a mixture of herbal extracts, including ginger-processed Pinellia ternate (半夏), Gentian (龙胆), Costus root (木香), Rhubarb (大黄), and Fructus Aurantii Immaturus (枳实). Weili Tablets are indicated for the treatment of gastrointestinal and biliary conditions, including acute gastritis, cholecystitis, dyspepsia, vomiting, and constipation. The medication works by promoting qi circulation, relieving pain, harmonizing the stomach, facilitating gallbladder function, and resolving food stagnation.

Brand names: Weili Tablets
Other names: Weili Pian胃力片

Beyond the preview

Go deeper on Weili Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Weili Tablets.

Explore the full profile